Contract facts
FederalNo full NAICS 325412 intel page yet. Browse NAICS intelligence
INMATE BIOLOGIC GAMMAGARD is a federal award for Fmc Forth Worth held by Takeda Pharmaceuticals America, Inc. Estimated value $492K ($486K obligated). Current period of performance ends Oct 30, 2022. Last award drew 1 bidder. Place of performance: LEXINGTON MA.
Recompete timing
PublicCurrent PoP ended Oct 30, 2022 (1391 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Incumbent footprint
Public recordTakeda Pharmaceuticals America, Inc — $6.5M obligated across 96 awards (firm-wide, all agencies) · lead buyer Department of Justice (DOJ).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 15B50922F00000080?
15B50922F00000080 (INMATE biologic gammagard) is a Fmc Forth Worth award with a potential value of $492K, currently held by Takeda Pharmaceuticals America, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded 15B50922F00000080?
Fmc Forth Worth awarded 15B50922F00000080 to Takeda Pharmaceuticals America, Inc (potential $492K).
Who is the incumbent on 15B50922F00000080?
Takeda Pharmaceuticals America, Inc is the incumbent with $6.5M across 96 related awards in SCOUT’s public footprint. The current period of performance ends Oct 30, 2022.
When does Takeda Pharmaceuticals America, Inc’s 15B50922F00000080 come up for recompete?
SCOUT tracks a period-of-performance end of Oct 30, 2022. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.